| Reaction Details |
|---|
 | Report a problem with these data |
| Target | MAP kinase-activated protein kinase 5 |
|---|
| Ligand | BDBM50001733 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_1337321 (CHEMBL3241183) |
|---|
| IC50 | >10000±n/a nM |
|---|
| Citation |  Mahmoud, KA; Krug, M; Wersig, T; Slynko, I; Schächtele, C; Totzke, F; Sippl, W; Hilgeroth, A Discovery of 4-anilinoa-carbolines as novel Brk inhibitors. Bioorg Med Chem Lett24:1948-51 (2014) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| MAP kinase-activated protein kinase 5 |
|---|
| Name: | MAP kinase-activated protein kinase 5 |
|---|
| Synonyms: | MAP kinase-activated protein kinase 5 (PRAK) | MAPK-Activated Protein Kinase 5 (MK5) | MAPK-activated protein kinase 5 | MAPK5_HUMAN | MAPKAP kinase 5 | MAPKAPK5 | PRAK | p38-regulated/activated protein kinase | p38-regulated/activated protein kinase (PRAK) |
|---|
| Type: | Serine/threonine-protein kinase |
|---|
| Mol. Mass.: | 54229.92 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | Recombinant MAPKAPK5 was phosphorylated by incubation with active p38alpha before assays. |
|---|
| Residue: | 473 |
|---|
| Sequence: | MSEESDMDKAIKETSILEEYSINWTQKLGAGISGPVRVCVKKSTQERFALKILLDRPKAR
NEVRLHMMCATHPNIVQIIEVFANSVQFPHESSPRARLLIVMEMMEGGELFHRISQHRHF
TEKQASQVTKQIALALRHCHLLNIAHRDLKPENLLFKDNSLDAPVKLCDFGFAKIDQGDL
MTPQFTPYYVAPQVLEAQRRHQKEKSGIIPTSPTPYTYNKSCDLWSLGVIIYVMLCGYPP
FYSKHHSRTIPKDMRRKIMTGSFEFPEEEWSQISEMAKDVVRKLLKVKPEERLTIEGVLD
HPWLNSTEALDNVLPSAQLMMDKAVVAGIQQAHAEQLANMRIQDLKVSLKPLHSVNNPIL
RKRKLLGTKPKDSVYIHDHENGAEDSNVALEKLRDVIAQCILPQAGKGENEDEKLNEVMQ
EAWKYNRECKLLRDTLQSFSWNGRGFTDKVDRLKLAEIVKQVIEEQTTSHESQ
|
|
|
|---|
| BDBM50001733 |
|---|
| n/a |
|---|
| Name | BDBM50001733 |
|---|
| Synonyms: | CHEMBL3133821 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C17H13N3O |
|---|
| Mol. Mass. | 275.3046 |
|---|
| SMILES | Oc1cccc(Nc2ccnc3[nH]c4ccccc4c23)c1 |
|---|
| Structure | 
|
|---|
Search and Browse
